Italy Diagnostic Labs Market By Provider Type (Hospital, Stand-Alone Centre, Diagnostic Chains), By Test Type (Radiology v/s Pathology), By End User (Corporate Clients, Walk-ins, Referrals), By Region, Competition Forecast & Opportunities, 2027

The Italy diagnostic labs market is anticipated to grow at a steady CAGR in the forecast period, 2023-2027. The rise in consumer awareness about the benefits of preventive healthcare practices is accelerating the demand for diagnostic tests and procedures for the early diagnosis of diseases. The government is focusing on the development of an efficient healthcare system by allocating huge funds and hiring skilled professionals, which is expected to affect the Italy diagnostic labs market positively. Also, public and private players support the ongoing extensive research and development activities to upgrade the existing infrastructure and improve the accuracy of test results are expected to create lucrative growth opportunities for the Italy diagnostic labs market over the forecast period.

Growing Prevalence of Chronic Diseases and Lifestyle Disorders Drives the Market Demand

The vast majority of the old-age population in Italy is vulnerable and prone to several diseases. They require the help of healthcare services to gain and maintain their health and actively invest in diagnostic tests and procedures that help decide the better drug course for patients. Also, the adoption of a sedentary lifestyle and unhealthy eating habits gives rise to many diseases among the youth and old age population. Stroke, lung cancer, diabetes, neurological disorders, and cardiovascular disorders are among Italy's most common lifestyle diseases. Many patients who suffer from cardiovascular disorders die due to late disease detection. Patients are becoming more health-conscious; therefore, they prefer to avail themselves of the diagnostic labs at the earliest. The growing occurrence of various types of diseases and the availability of a large number of diagnostic labs across the country are expected to fuel the growth of the Italy diagnostic labs market over the next five years.

Booming Healthcare Industry Drives the Market Demand

The healthcare industry is ranked best across the world. The National Health Service was created in 1978, and in 2000, World Health Organization (WHO) named it as second best in the world. The healthcare sector in Italy is a regionally based national health service which is known by the name of Servizio Sanitario Nazionale (SSN). It provides universal healthcare coverage to all of its citizens, which is free of charge at the point of delivery. The major source of financing for the healthcare industry is through national and regional taxes and copayments for outpatient care and the pharmaceuticals industry. Public or private healthcare facilities provide visits by specialist doctors or diagnostic tests through the national health service and are free of cost.

Ongoing Technological Advancements Support the High Market Demand

Government authorities are investing hefty amounts and introducing supportive rules and policies to accelerate the growth of the healthcare industry. The digitization of diagnostic laboratories and healthcare facilities is expected to improve the quality of services offered to patients significantly. The records of the patients can be easily maintained, and the test results can be digitally transferred to patients, which eliminates the need for unnecessary visits to the healthcare facilities. Also, the availability of novel diagnostic devices and technologies in the market and the emergence of online sales channels are expected to play a crucial role in accelerating the growth of the Italy diagnostic labs market over the next five years.

Click here to download the sample

Market Segmentation

The Italy diagnostic labs market is divided into provider type, test type, end user, regional distribution, and competitive landscape. Based on provider type, the market is divided into

Market Players

Medelit, Giesse Diagnostics S.r.l., EKF Diagnostics Holdings plc, Bioaesis, Affidea Group are the major market players operating in the Italy diagnostic labs market.